Search Results - "Bortolozzi, Analía"

Refine Results
  1. 1

    Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research by Celada, Pau, Bortolozzi, Analía, Artigas, Francesc

    Published in CNS drugs (01-09-2013)
    “…Psychiatric disorders represent a large economic burden in modern societies. However, pharmacological treatments are still far from optimal. Drugs used in the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Overexpression of TFEB Drives a Pleiotropic Neurotrophic Effect and Prevents Parkinson’s Disease-Related Neurodegeneration by Torra, Albert, Parent, Annabelle, Cuadros, Thais, Rodríguez-Galván, Beatriz, Ruiz-Bronchal, Esther, Ballabio, Andrea, Bortolozzi, Analía, Vila, Miquel, Bové, Jordi

    Published in Molecular therapy (06-06-2018)
    “…The possible implication of transcription factor EB (TFEB) as a therapeutic target in Parkinson’s disease has gained momentum since it was discovered that TFEB…”
    Get full text
    Journal Article
  4. 4

    In vivo knockdown of astroglial glutamate transporters GLT-1 and GLAST increases excitatory neurotransmission in mouse infralimbic cortex: Relevance for depressive-like phenotypes by Fullana, Mª Neus, Covelo, Ana, Bortolozzi, Analía, Araque, Alfonso, Artigas, Francesc

    Published in European neuropsychopharmacology (01-11-2019)
    “…Alterations of energy metabolism and of astrocyte number/function in ventral anterior cingulate cortex (vACC) have been reported in major depressive disorder…”
    Get full text
    Journal Article
  5. 5

    Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex by Santana, Noemí, Bortolozzi, Analía, Serrats, Jordi, Mengod, Guadalupe, Artigas, Francesc

    Published in Cerebral cortex (New York, N.Y. 1991) (01-10-2004)
    “…Serotonergic 5-HT1A and 5-HT2A receptors are abundantly expressed in prefrontal cortex (PFC) and are targets of atypical antipsychotic drugs. They mediate,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Selective enhacement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia by Masana, Mercè, Bortolozzi, Analía, Artigas, Francesc

    “…The superior efficacy of atypical vs. classical antipsychotic drugs to treat negative symptoms and cognitive deficits in schizophrenia appears related to their…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity by Bortolozzi, Analía, Díaz‐Mataix, Llorenç, Scorza, M. Cecilia, Celada, Pau, Artigas, Francesc

    Published in Journal of neurochemistry (01-12-2005)
    “…Atypical antipsychotics show preferential 5‐HT2A versus dopamine (DA) D2 receptor affinity. At clinical doses, they fully occupy cortical 5‐HT2 receptors,…”
    Get full text
    Journal Article
  10. 10

    Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review by Masana, Mercè, Santana, Noemí, Artigas, Francesc, Bortolozzi, Analía

    Published in Current topics in medicinal chemistry (01-11-2012)
    “…Schizophrenia has been historically characterized by the presence of positive symptomatology, however, decades of research highlight the importance of…”
    Get more information
    Journal Article
  11. 11

    Acute 5-HT1A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions by Ferrés-Coy, Albert, Santana, Noemí, Castañé, Anna, Cortés, Roser, Carmona, María C., Toth, Miklos, Montefeltro, Andrés, Artigas, Francesc, Bortolozzi, Analía

    Published in Psychopharmacology (01-01-2013)
    “…Rationale Identifying the etiological factors in anxiety and depression is critical to develop more efficacious therapies. The inhibitory serotonin 1A…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Strategies for producing faster acting antidepressants by Adell, Albert, Castro, Elena, Celada, Pau, Bortolozzi, Analéa, Pazos, Angel, Artigas, Francesc

    Published in Drug Discovery Today (15-04-2005)
    “…The global impact of depression is growing but there have been no substantial advances to overcome two main problems of its treatment: slowness and limited…”
    Get full text
    Book Review Journal Article
  15. 15

    Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells by Altarche-Xifro, Wassim, di Vicino, Umberto, Muñoz-Martin, Maria Isabel, Bortolozzi, Analía, Bové, Jordi, Vila, Miquel, Cosma, Maria Pia

    Published in EBioMedicine (01-06-2016)
    “…Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and…”
    Get full text
    Journal Article
  16. 16

    A Functional Leptin System Is Essential for Sodium Tungstate Antiobesity Action by Canals, Ignasi, Carmona, María C, Amigó, Marta, Barbera, Albert, Bortolozzi, Analía, Artigas, Francesc, Gomis, Ramon

    Published in Endocrinology (Philadelphia) (01-02-2009)
    “…Sodium tungstate is a novel agent in the treatment of obesity. In diet-induced obese rats, it is able to reduce body weight gain by increasing energy…”
    Get full text
    Journal Article
  17. 17

    Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies by Artigas, Francesc, Bortolozzi, Analia, Celada, Pau

    Published in European neuropsychopharmacology (01-04-2018)
    “…Major depressive disorder (MDD) is a severe psychiatric syndrome with high prevalence and socioeconomic impact. Current antidepressant treatments are based on…”
    Get full text
    Journal Article
  18. 18

    In vivo efflux of serotonin in the dorsal raphe nucleus of 5‐HT1A receptor knockout mice by Bortolozzi, Analía, Amargós‐Bosch, Mercè, Toth, Miklos, Artigas, Francesc, Adell, Albert

    Published in Journal of neurochemistry (01-03-2004)
    “…In the dorsal raphe nucleus (DR), extracellular serotonin (5‐HT) regulates serotonergic transmission through 5‐HT1A autoreceptors. In this work we used in vivo…”
    Get full text
    Journal Article
  19. 19

    Astrocyte control of glutamatergic activity: Downstream effects on serotonergic function and emotional behavior by Fullana, Neus, Gasull-Camós, Júlia, Tarrés-Gatius, Mireia, Castañé, Anna, Bortolozzi, Analía, Artigas, Francesc

    Published in Neuropharmacology (01-04-2020)
    “…Major depressive disorder (MDD) is a leading cause of disability worldwide, with a poorly known pathophysiology and sub-optimal treatment, based on serotonin…”
    Get full text
    Journal Article
  20. 20

    Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson’s Disease by Duperrier, Sandra, Bortolozzi, Analia, Sgambato, Véronique

    “…Parkinson’s disease (PD) is characterized by cell loss in the substantia nigra and the presence of alpha-synuclein (α-syn)-containing neuronal Lewy bodies…”
    Get full text
    Journal Article